Related references
Note: Only part of the references are listed.Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-L-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic
Markus Hutterer et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis
Praneil Patel et al.
NEURO-ONCOLOGY (2017)
Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI
S. Wang et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
Ovidiu C. Andronesi et al.
CLINICAL CANCER RESEARCH (2016)
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET
Sied Kebir et al.
CLINICAL CANCER RESEARCH (2016)
Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [18F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience
Otto M. Henriksen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Early static 18F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans
Nathalie L. Albert et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis
Qun Wang et al.
EUROPEAN RADIOLOGY (2016)
Perfusion MRI in the Evaluation of Suspected Glioblastoma Recurrence
Stella Blasel et al.
JOURNAL OF NEUROIMAGING (2016)
Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma
Mark S. Shiroishi et al.
NEURO-ONCOLOGY (2016)
Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis
Vincent Dunet et al.
NEURO-ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
Elizabeth R. Gerstner et al.
CLINICAL CANCER RESEARCH (2016)
Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab
F. Stephen Hodi et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?
Marcus Unterrainer et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Response to: Performance of 18F-FET-PET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: inherent bias in meta-analysis not revealed by quality metrics
Vincent Dunet et al.
NEURO-ONCOLOGY (2016)
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L. Albert et al.
NEURO-ONCOLOGY (2016)
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases
Sied Kebir et al.
NEURO-ONCOLOGY (2016)
Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics
Jurgita Usinskiene et al.
NEURORADIOLOGY (2016)
TSPO expression in brain tumours: is TSPO a target for brain tumour imaging?
Federico Roncaroli et al.
CLINICAL AND TRANSLATIONAL IMAGING (2016)
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI
Francesco Cicone et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging
Osamu Manabe et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
The 18-kDa Mitochondrial Translocator Protein in Human Gliomas: An 11C-(R)PK11195 PET Imaging and Neuropathology Study
Zhangjie Su et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
TSPO Imaging in Glioblastoma Multiforme: A Direct Comparison Between 123I-CLINDE SPECT, 18F-FET PET, and Gadolinium-Enhanced MR Imaging
Per Jensen et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?
Norbert Galldiks et al.
NEURO-ONCOLOGY (2015)
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM
Bogdana Suchorska et al.
NEUROLOGY (2015)
31P-MRS of healthy human brain: ATP synthesis, metabolite concentrations, pH, and T1 relaxation times
Jimin Ren et al.
NMR IN BIOMEDICINE (2015)
Advances in Magnetic Resonance Imaging and Positron Emission Tomography Imaging for Grading and Molecular Characterization of Glioma
Caroline Chung et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
Perspectives of Ultra-High-Field MRI in Neuroradiology
E. R. Gizewski et al.
CLINICAL NEURORADIOLOGY (2015)
Correlation of 18F-fluoroethyl tyrosine positron-emission tomography uptake values and histomorphological findings by stereotactic serial biopsy in newly diagnosed brain tumors using a refined software tool
William Omar Contreras Lopez et al.
ONCOTARGETS AND THERAPY (2015)
[18F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas
S. Collet et al.
NEUROIMAGE-CLINICAL (2015)
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
Serena Pellegatta et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET)
A. Habermeier et al.
AMINO ACIDS (2015)
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET
Norbert Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses
Niklas Thon et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma
Nathalie L. Jansen et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment
Ryogo Minamimoto et al.
PLOS ONE (2015)
Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma
B. M. Ellingson et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2014)
Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy
Johannes Schwarzenberg et al.
CLINICAL CANCER RESEARCH (2014)
18F-DOPA, a Clinically Available PET Tracer to Study Brain Inflammation?
Quentin Sala et al.
CLINICAL NUCLEAR MEDICINE (2014)
Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: A systematic review and meta-analysis
Hui Zhang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
Letter to the Editor: The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline [J Neurooncol 2014; 118:435-460]
Karl-Josef Langen et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab
Rifaquat Rahman et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
The role of imaging in the management of progressive glioblastoma
Timothy Charles Ryken et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Dynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients
Nathalie L. Jansen et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
F-18-FDOPA PET for Differentiating Recurrent or Progressive Brain Metastatic Tumors from Late or Delayed Radiation Injury After Radiation Treatment
Karlo J. Lizarraga et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Comparison of 18F-FET PET and Perfusion-Weighted MR Imaging: A PET/MR Imaging Hybrid Study in Patients with Brain Tumors
Christian P. Filss et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors
Clemens Kratochwil et al.
NEURO-ONCOLOGY (2014)
Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma
Kathleen M. Schmainda et al.
NEURO-ONCOLOGY (2014)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
An Intra-Individual Comparison of MRI, [18F]-FET and [18F]-FLT PET in Patients with High-Grade Gliomas
Martha Nowosielski et al.
PLOS ONE (2014)
In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma
Koji Sagiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Added value of advanced over conventional magnetic resonance imaging in grading gliomas and other primary brain tumors
Juan A. Guzman-De-Villoria et al.
CANCER IMAGING (2014)
Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
Hideo Nakamura et al.
ACTA RADIOLOGICA (2013)
Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging
Young Jun Choi et al.
ACTA RADIOLOGICA (2013)
Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis
T. Nihashi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
Correlation of MRI-Derived Apparent Diffusion Coefficients in Newly Diagnosed Gliomas with [18F]-Fluoro-L-Dopa PET: What Are We Really Measuring with Minimum ADC?
S. Rose et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT
Sellam Karunanithi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
The role of LAT1 in 18F-DOPA uptake in malignant gliomas
Ryan S. Youland et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
Marion Rapp et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET as a Diagnostic Tool for Detection of Malignant Progression in Patients with Low-Grade Glioma
Norbert Galldiks et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
In vivo imaging of glucose uptake and metabolism in tumors
Simon Walker-Samuel et al.
NATURE MEDICINE (2013)
[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma
Markus Hutterer et al.
NEURO-ONCOLOGY (2013)
Usefulness of FMISO-PET for Glioma Analysis
Hiroyuki Kobayashi et al.
NEUROLOGIA MEDICO-CHIRURGICA (2013)
Clinical value of O-(2-[18F]-fluoroethyl)-L-tyrosine positron emission tomography in patients with low-grade glioma
Marion Rapp et al.
NEUROSURGICAL FOCUS (2013)
Genomic Mapping and Survival Prediction in Glioblastoma: Molecular Subclassification Strengthened by Hemodynamic Imaging Biomarkers
Rajan Jain et al.
RADIOLOGY (2013)
The Added Value of Apparent Diffusion Coefficient to Cerebral Blood Volume in the Preoperative Grading of Diffuse Gliomas
A. Hilario et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
The translocator protein ligand [18F]DPA-714 images glioma and activated microglia in vivo
Alexandra Winkeler et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?
Nathalie L. Jansen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study
Whitney B. Pope et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
Norbert Galldiks et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis
Norbert Galldiks et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis
Vincent Dunet et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas
Changho Choi et al.
NATURE MEDICINE (2012)
Epidemiology of Brain Metastases
Lakshmi Nayak et al.
CURRENT ONCOLOGY REPORTS (2012)
Correlation of MR Relative Cerebral Blood Volume Measurements with Cellular Density and Proliferation in High-Grade Gliomas: An Image-Guided Biopsy Study
S. J. Price et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2011)
Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
L. C. Hygino da Cruz et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2011)
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for Glioma Grading Assessment of Individual Probability of Malignancy
Maria Lucia Calcagni et al.
CLINICAL NUCLEAR MEDICINE (2011)
AN INTERINDIVIDUAL COMPARISON OF O-(2-[18F]FLUOROETHYL)-L-TYROSINE (FET)- AND L-[METHYL-11C]METHIONINE (MET)-PET IN PATIENTS WITH BRAIN GLIOMAS AND METASTASES
Anca-Ligia Grosu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
PROGNOSTIC VALUE OF EARLY [18F]FLUOROETHYLTYROSINE POSITRON EMISSION TOMOGRAPHY AFTER RADIOCHEMOTHERAPY IN GLIOBLASTOMA MULTIFORME
Marc D. Piroth et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Heterogeneity in malignant gliomas: a magnetic resonance analysis of spatial distribution of metabolite changes and regional blood volume
Marlies Wagner et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery
Stella Blasel et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement
Georg Widhalm et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma
Markus Hutterer et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Hot spots in dynamic 18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas
M. Kunz et al.
NEURO-ONCOLOGY (2011)
Magnetic Resonance Spectroscopic Imaging for Visualization of the Infiltration Zone of Glioma
A. Stadlbauer et al.
CENTRAL EUROPEAN NEUROSURGERY (2011)
Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?
Robert Pichler et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas
Michail Plotkin et al.
EUROPEAN RADIOLOGY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Correlation of l-methyl-11C-methionine (MET) uptake with l-type amino acid transporter 1 in human gliomas
Shuichi Okubo et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Imaging of Brain Tumors: MR Spectroscopy and Metabolic Imaging
Alena Norska et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2010)
1H MRSI and progression-free survival in patients with WHO grades II and III gliomas
Elke Hattingen et al.
NEUROLOGICAL RESEARCH (2010)
Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
L. S. Hu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
Pseudoprogression and pseudoresponse in the treatment of gliomas
Dieta Brandsma et al.
CURRENT OPINION IN NEUROLOGY (2009)
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy
Suja Saraswathy et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
被撤回的出版物: Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging (Retracted article. See vol. 114, pg. 255, 2013)
H. R. Arvinda et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours
Elke Hattingen et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2009)
DIAGNOSTIC VALUE OF PROTON MAGNETIC RESONANCE SPECTROSCOPY IN THE NONINVASIVE GRADING OF SOLID GLIOMAS: COMPARISON OF MAXIMUM AND MEAN CHOLINE VALUES
Christian Senft et al.
NEUROSURGERY (2009)
Comparison of 18F-FET and 18F-FDG PET in brain tumors
Dirk Pauleit et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Prognostic value of perfusion MR imaging of high-grade astrocytomas: Long-term follow-up study
T. Hirai et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation
Vlariko Toyooka et al.
CLINICAL IMAGING (2008)
Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI
Nicolas Fayed et al.
EUROPEAN JOURNAL OF RADIOLOGY (2008)
Metabolic imaging of cerebral gliomas:: Spatial correlation of changes in O-(2-18F-fluoroethyl)L-tyrosine PET and proton magnetic resonance spectroscopic imaging
Andreas Stadlbauer et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy
Yuzo Terakawa et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Prognostic value of choline and creatine in WHO grade II gliomas
Elke Hattingen et al.
NEURORADIOLOGY (2008)
Gliomas: Predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging
Meng Law et al.
RADIOLOGY (2008)
Apparent diffusion coefficient and cerebral mood volume in brain gliomas: Relation to tumor cell density and tumor microvessel density based on seterotactic biopsies
N. Sadeghi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
C-11-L-methionine positron emission tomography in the clinical management of cerebral gliomas
Tarun Singhal et al.
MOLECULAR IMAGING AND BIOLOGY (2008)
Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses
Daumar Salber et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
FET PET for the evaluation of untreated gliomas:: correlation of FET uptake and uptake kinetics with tumour grading
Gabriele Poepperl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Non-invasive grading of brain tumours using dynamic amino acid PET imaging:: does it work for 11C-Methionine?
Gerard Moulin-Romsee et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Metabolic and molecular imaging in neuro-oncology
Karl Herholz et al.
LANCET NEUROLOGY (2007)
Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma
Frank W. Floeth et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Clinical applications of PET in brain tumors
Wei Chen
JOURNAL OF NUCLEAR MEDICINE (2007)
Serial O-(2-[18F] fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma
Gabriele Poepperl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas
N Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Metabolic differences between human brain tumors:: a 1H NMR primary and recurrent spectroscopic investigation
FG Lehnhardt et al.
NMR IN BIOMEDICINE (2005)
Positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas
W Rachinger et al.
NEUROSURGERY (2005)
O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma
G Pöpperl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas
H Ohgaki et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Functional diffusion map: A noninvasive MR1 biomarker for early stratification of clinical brain tumor response
BA Moffat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours
M Weckesser et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas
D Pauleit et al.
BRAIN (2005)
Multimodal metabolic imaging of cerebral gliomas:: positron emission tomography with [18F] fluoroethyl-L-tyrosine and magnetic resonance spectroscopy
FW Floeth et al.
JOURNAL OF NEUROSURGERY (2005)
C-11-methionine PET as a prognostic marker in patients with glioma: comparison with F-18-FDG PET
S Kim et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies
B Pirotte et al.
JOURNAL OF NEUROSURGERY (2004)
Delineation of brain tumor extent with [11C]L-methionine positron emission tomography:: Local comparison with stereotactic histopathology
LW Kracht et al.
CLINICAL CANCER RESEARCH (2004)
Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts
R Kreis
NMR IN BIOMEDICINE (2004)
Brain tumour imaging with PET:: a comparison between [18F]fluorodopa and [11C]methionine
A Becherer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
N Tsuyuguchi et al.
JOURNAL OF NEUROSURGERY (2003)
The potential of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis and management of patients with brain tumors
X Leclerc et al.
CURRENT OPINION IN ONCOLOGY (2002)
Target volumes in radiotherapy for high-grade malignant glioma of the brain
EPM Jansen et al.
RADIOTHERAPY AND ONCOLOGY (2000)
A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)
KM Ward et al.
JOURNAL OF MAGNETIC RESONANCE (2000)
Share Paper
